Financings

Feb. 25, 2021
By David Ho
Wuxi Diagnostics raises $150M in series B financing
HONG KONG – Wuxi Diagnostic Investment (Cayman) Ltd. has raised $150 million in a series B financing round, while netting a number of new investors along the way. The new investors to come on board include Thermo Fisher Scientific Inc., Shiyu Capital, ABC International Holdings Ltd., Sunland Capital and CCBI Tech Venture.
Feb. 25, 2021
Financings for Feb. 25, 2021
Med-tech firms raising money in public or private financings, including: January AI, Miroculus, Redox, Xtant Medical Holdings.
Feb. 25, 2021
By Elise Mak
Yisheng moves COVID-19 vaccine to clinic after $130M series B
Eight months after Beijing-based Yisheng Biopharma Co. Ltd. unveiled its recombinant protein vaccine candidate for COVID-19, YS-SC2-010, the company raised $130 million in a series B round to pave way for the vaccine to enter clinical trials in the second quarter of this year, the company’s CEO David Shao told BioWorld.

Wuxi Diagnostics raises $150M in series B financing